Biosensors & bioelectronics

DNA-triggered CRISPR/Cas12a circuit for highly sensitive and flexible biosensing

Updated

Abstract

The CBD biosensing platform achieves a detection limit of 14 CFU/mL for methicillin-resistant Staphylococcus aureus.

  • A bulge DNA (BD)-driven activation circuit enhances the sensitivity of the CRISPR/Cas12a biosensing tool.
  • For nucleic acid targets, the system initiates a positive feedback loop that amplifies detection signals.
  • Detection of pesticides and mycotoxins is possible at the picogram-per-milliliter level through a universal single-stranded DNA activator.
  • An 'OR' logic gate allows for simultaneous detection of two mycotoxins, demonstrating multiplexing capabilities.
  • The CBD platform shows versatility for both nucleic acid and non-nucleic acid target detection.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free